1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South and Central America Cancer Radiation Therapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South and Central America Cancer Radiation Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South and Central America Cancer Radiation Therapy Market Regional Analysis
6.2 South and Central America Cancer Radiation Therapy Market Revenue 2021-2031 (US$ Million)
6.3 South and Central America Cancer Radiation Therapy Market Forecast Analysis
7. South and Central America Cancer Radiation Therapy Market Analysis – by Type
7.1 External Beam Radiation Therapy
- 7.1.1 Overview
- 7.1.2 External Beam Radiation Therapy: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
- 7.2.1 Overview
- 7.2.2 Internal Beam Radiation Therapy: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. South and Central America Cancer Radiation Therapy Market Analysis – by Cancer Type
8.1 Lung Cancer
- 8.1.1 Overview
- 8.1.2 Lung Cancer: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Breast Cancer
- 8.2.1 Overview
- 8.2.2 Breast Cancer: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Colorectal Cancer
- 8.3.1 Overview
- 8.3.2 Colorectal Cancer: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Prostate Cancer
- 8.4.1 Overview
- 8.4.2 Prostate Cancer: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Head & Neck Cancer
- 8.5.1 Overview
- 8.5.2 Head & Neck Cancer: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Cervical Cancer
- 8.6.1 Overview
- 8.6.2 Cervical Cancer: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Other Cancer Types
- 8.7.1 Overview
- 8.7.2 Other Cancer Types: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. South and Central America Cancer Radiation Therapy Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Ambulatory and Radiotherapy Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory and Radiotherapy Centers: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Academic and Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic and Research Institutes: South and Central America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. South and Central America Cancer Radiation Therapy Market – South and Central America Analysis
10.1 Overview
10.2 South and Central America
- 10.2.1 South and Central America Cancer Radiation Therapy Market Breakdown, by Key
Country, 2025 and 2031 (%)
- 10.2.1.1 South and Central America Cancer Radiation Therapy Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Brazil:
South and Central America Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 Brazil: South and Central America Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.1.2 Brazil: South and Central America Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.1.3 Brazil: South and Central America Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.2 Argentina:
South and Central America Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Argentina: South and Central America Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.2.2 Argentina: South and Central America Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.2.3 Argentina: South and Central America Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.3 Chile:
South and Central America Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Chile: South and Central America Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.3.2 Chile: South and Central America Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.3.3 Chile: South and Central America Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.4 Colombia:
South and Central America Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Colombia: South and Central America Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.4.2 Colombia: South and Central America Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.4.3 Colombia: South and Central America Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.5 Peru:
South and Central America Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.5.1 Peru: South and Central America Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.5.2 Peru: South and Central America Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.5.3 Peru: South and Central America Cancer Radiation Therapy Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Siemens Healthineers
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Accuray Incorporated
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Elekta
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Brainlab AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 RefleXion
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Hitachi Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 IBA Worldwide
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 GT Medical Technologies, Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Mevion Medical Systems
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Theragenics Corporation
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations